Telitacicept
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
Peking University Third Hospital
Overview
Telitacicept is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
Telitacicept clinical trials
Explore related
Medical disclaimer. This page summarizes research about Telitacicept for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.